Immunology

Items 1001-1010 of 1195

per page
Set Descending Direction
  1. Fc (human):FasL, Soluble (human) (rec.)
    AG-40B-0132
    AG-40B-0132-C01010 µg
    CHF 335.00
    AG-40B-0132-30103 x 10 µg
    CHF 670.00
    Oligomerisation of FasL (h) efficiently triggers Jurkat cell death.Method: Jurkat cells were treated O/N with the indicated concentrations of MegaFasL, Soluble (human) (rec.) (Prod. No. AG-40B-0130), Fc:FasL, Soluble (human) (rec.) (Pr
  2. Fc (human):Grancalcin (human) (rec.)
    AG-40B-0242
    AG-40B-0242-C05050 µg
    CHF 440.00
  3. Fc (human):OX40L, Soluble (human) (rec.)
    AG-40B-0172
    AG-40B-0172-C01010 µg
    CHF 230.00
    AG-40B-0172-30103 x 10 µg
    CHF 455.00
  4. Fc (LALA-PG)-KIH (human):GDF15 (human) (rec.)
    AG-40B-0253
    AG-40B-0253-C05050 µg
    CHF 440.00
    NEW Fc (LALA-PG)-KIH (human):GDF15 (human) (rec.)
  5. Fc (LALA-PG)-KIH (human):Irisin (monomeric) (rec.)
    AG-40B-0246
    AG-40B-0246-C05050 µg
    CHF 440.00

    Replaces AG-40B-0115

    Fc (LALA-PG)-KIH (human):Irisin (monomeric) (rec.)
  6. FGF-1 (human) (rec.)
    AG-40B-0137
    AG-40B-0137-C01010 µg
    CHF 120.00
    AG-40B-0137-30103 x 10 µg
    CHF 240.00
  7. FGF-2 (human) (rec.)
    AG-40T-0040
    AG-40T-0040-C01010 µg
    CHF 150.00
    AG-40T-0040-C05050 µg
    CHF 270.00
  8. FGF-2 (human) (rec.) (untagged)
    AG-40B-0150
    AG-40B-0150-C01010 µg
    CHF 120.00
    AG-40B-0150-30103 x 10 µg
    CHF 240.00
  9. FGL1 (human) ELISA Kit
    AG-45B-0022
    AG-45B-0022-KI0196 wells
    CHF 610.00
    FGL1 (human) ELISA Kit
  10. Flagellin (NLRC4 Mutant) (rec.)
    AG-40B-0126
    AG-40B-0126-C01010 µg
    CHF 215.00
    AG-40B-0126-30103 x 10 µg
    CHF 480.00
    Flagellin (rec.) (AG-40B-0125) and Flagellin (NLRC4 Mutant) (rec.) (AG-40B-0126) induce CCL20-luciferase promoter through TLR5 in vitro. Method: Caco-2 cells transfected with plasmid encoding CCL20-LUC plasmid are activated for 24h wit

Items 1001-1010 of 1195

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.